Adage Capital Partners
WVE icon

Adage Capital Partners’s Wave Life Sciences WVE Stock Holding History

Adage Capital Partners’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,000,000
Closed -$7.25M – 1100
2026
Q1 		$7.25M Sell
1,000,000
-8,786,061
-90% -$114M 0.01% 740
2025
Q4 		$166M Sell
9,786,061
-4,781,723
-33% -$48.6M 0.25% 68
2025
Q3 		$107M Sell
14,567,784
-448,716
-3% -$3.63M 0.17% 117
2025
Q2 		$97.6M Buy
15,016,500
+2,500,000
+20% +$16.5M 0.16% 120
2025
Q1 		$101M Buy
12,516,500
+2,894,396
+30% +$31.7M 0.19% 109
2024
Q4 		$119M Sell
9,622,104
-81,247
-0.8% -$1.08M 0.21% 91
2024
Q3 		$79.6M Buy
9,703,351
+4,345,632
+81% +$26M 0.14% 147
2024
Q2 		$26.7M Buy
5,357,719
+156,330
+3% +$892K 0.05% 363
2024
Q1 		$32.1M Sell
5,201,389
-786,341
-13% -$3.94M 0.06% 337
2023
Q4 		$30.2M Buy
5,987,730
+2,200,000
+58% +$11.8M 0.06% 317
2023
Q3 		$21.8M Sell
3,787,730
-831,179
-18% -$3.79M 0.05% 372
2023
Q2 		$16.8M Hold
4,618,909
– – 0.04% 461
2023
Q1 		$20M Sell
4,618,909
-907,975
-16% -$4.16M 0.04% 413
2022
Q4 		$38.7M Buy
5,526,884
+4,125,495
+294% +$19M 0.09% 253
2022
Q3 		$5.06M Sell
1,401,389
-1,345,752
-49% -$4.46M 0.01% 779
2022
Q2 		$8.93M Buy
2,747,141
+2,297,141
+510% +$4.42M 0.02% 697
2022
Q1 		$900K Hold
450,000
– – ﹤0.01% 939
2021
Q4 		$1.41M Buy
450,000
+50,000
+13% +$208K ﹤0.01% 884
2021
Q3 		$1.96M Buy
+400,000
New +$2.43M ﹤0.01% 895

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Adage Capital Partners's WVE Position: Q2 2026 in Review

Adage Capital Partners sold out of Wave Life Sciences (WVE) in Q2 2026, closing a stake of 1,000,000 shares — an estimated $7.25M sold.

Adage Capital Partners first reported a position in WVE in Q3 2021 and held it in 19 quarters. The position peaked at $166M in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Adage Capital Partners reported no remaining Wave Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Adage Capital Partners sold 1,000,000 Wave Life Sciences shares in Q2 2026, an estimated $7.25M.
  • Adage Capital Partners first reported a position in Wave Life Sciences in Q3 2021 and held it in 19 quarters.
  • Adage Capital Partners's Wave Life Sciences position peaked at $166M in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.